| 1 |
35885481 |
10.3390/diagnostics12071575 |
2022 |
Cell-Free DNA for Genomic Analysis in Primary Mediastinal Large B-Cell Lymphoma. |
ITPKB |
| 2 |
35937947 |
10.1155/2022/6441139 |
2022 |
Genomic Mutation Landscape of Primary Breast Lymphoma: Next-Generation Sequencing Analysis. |
ITPKB |
| 3 |
31822802 |
10.1038/s41379-019-0428-0 |
2021 |
Diagnostic utility of STAT6<sup>YE361</sup> expression in classical Hodgkin lymphoma and related entities. |
ITPKB |
| 4 |
32079702 |
10.3324/haematol.2019.237719 |
2021 |
Targeted genotyping of circulating tumor DNA for classical Hodgkin lymphoma monitoring: a prospective study. |
ITPKB |
| 5 |
33684939 |
10.1182/blood.2020007683 |
2021 |
Characterization of DLBCL with a PMBL gene expression signature. |
ITPKB |
| 6 |
34925435 |
10.3389/fgene.2021.677650 |
2021 |
Genetic Landscape of Relapsed and Refractory Diffuse Large B-Cell Lymphoma: A Systemic Review and Association Analysis With Next-Generation Sequencing. |
ITPKB |
| 7 |
31697815 |
10.1182/blood.2019000032 |
2020 |
Inhibition of inositol kinase B controls acute and chronic graft-versus-host disease. |
ITPKB |
| 8 |
29650799 |
10.1182/blood-2017-11-814913 |
2019 |
Pervasive mutations of JAK-STAT pathway genes in classical Hodgkin lymphoma. |
ITPKB |
| 9 |
26819451 |
10.1158/1078-0432.CCR-15-2305 |
2018 |
Next-Generation Sequencing in Diffuse Large B-Cell Lymphoma Highlights Molecular Divergence and Therapeutic Opportunities: a LYSA Study. |
ITPKB |
| 10 |
26608593 |
10.1002/gcc.22328 |
2016 |
Whole exome sequencing of relapsed/refractory patients expands the repertoire of somatic mutations in diffuse large B-cell lymphoma. |
ITPKB |
Datasets
Models
